Gland Pharma Ltd. NSE: GLAND | BSE: 543245

Mid-range Performer

In 1 Starfolio Basket

Download real time

1689.70 13.80 (0.82%)

32.24% Gain from 52W Low

237.9K

NSE+BSE Volume

NSE 28 Jan, 2026 3:31 PM (IST)

Rapid Results

Q3FY26 Quarterly Result Announced for Gland Pharma Ltd. See details

Gland Pharma News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Gland Pharma from all sources in a single place.

Gland Pharma Ltd.

28 Jan 2026, 09:56PM

1689.70

0.82%

Gland Pharma Ltd. Results Earnings Call for Q3FY26

Conference Call with Gland Pharma Management and Analysts on Q3FY26 Performance and Outlook. Listen to the full earnings transcript.

Gland Pharma Ltd.

28 Jan 2026, 05:31PM

1689.70

0.82%

to see Rapid results content

Gland Pharma Ltd.

28 Jan 2026, 05:28PM

1689.70

0.82%

Investor Presentation

Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation on Q3FY26 Financial Results

Gland Pharma Ltd.

28 Jan 2026, 05:23PM

1689.70

0.82%

Company Update

Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release on Q3FY26 Financial Results

Gland Pharma Ltd.

28 Jan 2026, 05:18PM

1689.70

0.82%

Board Meeting

Gland Pharma Ltd - 543245 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

Outcome of Board Meeting held on January 28, 2026

Gland Pharma Ltd.

28 Jan 2026, 05:14PM

1689.70

0.82%

Result

Gland Pharma Ltd - 543245 - Unaudited Financial Results For The Quarter And Nine Months Ended …

BSE India

Unaudited Financial results for the quarter and nine months ended December 31, 2025

	Dec 2025	Sep 2025	Dec 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	1758.54	1571.04	1442.55	11.9%	21.9%
Operating Profit Qtr	434.88	313.89	359.96	38.5%	20.8%
Net Profit Qtr	261.48	183.68	204.69	42.4%	27.7%
Earning Per Share Adjusted latest Qtr	15.87	11.15	12.42	42.3%	27.8%

* Consolidated data

Detailed Results

Gland Pharma Ltd.

13 Jan 2026

1689.70

0.82%

Company Update

Gland Pharma Ltd - 543245 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018

Gland Pharma Ltd.

09 Jan 2026

1689.70

0.82%

Company Update

Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Q3FY26 Earnings Call Intimation

Gland Pharma Ltd.

09 Jan 2026

1689.70

0.82%

Board Meeting

Gland Pharma Ltd - 543245 - Board Meeting Intimation for Declaration Of Unaudited Financial Results For …

BSE India

Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and approve Unaudited Financial Results for the quarter and nine months ended December 31, 2025

Gland Pharma Ltd.

08 Jan 2026

1689.70

0.82%

Gland Pharma rises 5%, hits 1-month high on USFDA nod to eye-allergy drug

Business Standard

Gland Pharma jumped 4.80 per cent to 1,790.40, the highest level since December 3, 2025, on the National Stock Exchange.

Number of FII/FPI investors decreased from 260 to 236 in Dec 2025 qtr

VOTE: Is Gland Pharma Ltd. worth buying?

215 Votes:

Buy 80.93%

Sell 9.3%

Hold 9.77%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >